GSMQX
Price
$20.10
Change
-$0.06 (-0.30%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

GSMQX vs RPTIX

Header iconGSMQX vs RPTIX Comparison
Open Charts GSMQX vs RPTIXBanner chart's image
Goldman Sachs Small/Mid Cap Growth Svc
Price$20.10
Change-$0.06 (-0.30%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GSMQX vs RPTIX Comparison Chart
Loading...
VS
GSMQX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSMQX is a StrongBuy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. GSMQX (1.84B). RPTIX pays higher dividends than GSMQX: RPTIX (0.18) vs GSMQX (0.00). GSMQX was incepted earlier than RPTIX: GSMQX (19 years) vs RPTIX (9 years). GSMQX is a more actively managed with annual turnover of: 62.00 vs. RPTIX (21.70). GSMQX has a lower initial minimum investment than RPTIX: GSMQX (0) vs RPTIX (500000). GSMQX annual gain was more profitable for investors over the last year : 27.59 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. GSMQX (1.41).
GSMQXRPTIXGSMQX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years9 years-
Gain YTD13.4509.127147%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.84B31.4B6%
Annual Yield % from dividends0.000.18-
Returns for 1 year27.5914.81186%
Returns for 3 years-24.44-13.57180%
Returns for 5 years1.4115.099%
Returns for 10 years0.00N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp